INBIOGEN Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was KRW 150.68 million compared to KRW 927.79 million a year ago. Net income was KRW 807.38 million compared to net loss of KRW 7,014.57 million a year ago.
For the nine months, sales was KRW 1,530.73 million compared to KRW 4,311.44 million a year ago. Net income was KRW 19,419.52 million compared to net loss of KRW 134,580.97 million a year ago.